Cefuroxime Price Trend and Forecast 2026-2027

Germany is where the Cefuroxime story reads most clearly, so it is worth starting there. As the most expensive market on our panel, it carried the weight of the 2025 decline, easing from roughly USD 303,000/MT in the first quarter to about USD 285,000/MT by December, a loss of close to 5.9% over the year. Generic competition drove most of that erosion, and a well-supplied Chinese market added to the pressure. The global average followed the same downward path, sliding from USD 272,000/MT in the first quarter to USD 256,000/MT by the fourth, and it showed no real sign of steadying until the calendar turned. The low arrived in the first quarter of 2026 at around USD 253,000/MT, after which the market recovered modestly to USD 255,000/MT in the second quarter. That move was less a genuine rebound than a signal that the long slide had finally run its course, with the weakest sellers left with little room to cut further.

Cefuroxime (CAS 55268-75-2) is a second-generation cephalosporin antibiotic, traded most often as the axetil ester for oral formulations and as the sodium salt for injectable use. Its value to prescribers lies in its resistance to a broad range of bacterial beta-lactamase enzymes, which makes it a dependable choice across respiratory, urinary, skin, and ear infections. Production begins with the cephalosporin nucleus 7-ACA and moves through a sequence of semi-synthetic steps to reach finished API. China and India account for the majority of global output, while Italy and a handful of European sites cover the balance. Roughly two-thirds of demand sits in oral generics, with hospital injectables taking the remainder. On the cost side, four forces set the direction of price: the cost of 7-ACA and the downstream intermediates that feed the synthesis, the intensity of Chinese environmental compliance that periodically constrains cephalosporin output, the pace of generic competition that has steadily compressed margins across the category, and the seasonal lift in respiratory prescriptions through the winter months that lends demand a predictable annual rhythm.

Cefuroxime Price Forecast for 2026

The balance of supply and demand through the second half of 2026 points to a broadly steady market with a modest upward lean. The generic price erosion that defined last year has lost much of its force, largely because the most aggressive discounters have already cut close to the limits of their economics. The Chinese oversupply that weighed on the market for much of 2025 has substantially cleared. Feedstock, meanwhile, has reversed direction, with 7-ACA and intermediate costs now firming rather than falling and lending support to the production floor. Respiratory-season demand should hold at its customary pace into the fourth quarter. Taken together, these conditions favour a market that drifts sideways with a slightly higher floor rather than one that moves sharply in either direction.

The risks around that view are two-sided. On the upside, a sharp increase in 7-ACA cost, or a compliance-driven shutdown at a major Chinese cephalosporin facility, would tighten supply quickly and lift prices above the expected range. On the downside, a fresh wave of generic capacity, or a renewed round of aggressive discounting among Indian and Chinese exporters, would pull spot values back toward the lows recorded in 2025. Neither outcome represents the base case, but both remain plausible enough to warrant close attention through the second half of the year.

For the Quarter Ending June 2026

Cefuroxime Prices Q2 2026:

• United States: USD 278,000/MT
• China: USD 232,000/MT
• Germany: USD 286,000/MT
• India: USD 248,000/MT

Cefuroxime Prices in United States

The United States average settled at USD 278,000/MT in the second quarter, a modest gain of about 0.7% over the USD 276,000/MT recorded in the first. After a full year of steady erosion, the market appeared to establish a floor. Steadier generic pricing accounted for part of the recovery, while dearer imported intermediates provided additional support to the cost base.

Why did the price of Cefuroxime change in Q2 2026 in United States?

The prolonged discounting had largely exhausted itself, leaving sellers with little room to reduce offers further, and firmer 7-ACA costs lifted the production floor by a small margin. With respiratory demand holding steady through the quarter, US prices came to rest near USD 278,000/MT.

Cefuroxime Prices in China

China remained the most affordable source globally at USD 232,000/MT, a rise of roughly 0.9% from the USD 230,000/MT of the first quarter. Domestic producers had worked through the worst of their surplus, and rising environmental compliance costs gradually filtered into the cost base. Even so, the depth of Chinese cephalosporin capacity kept the market firmly anchored at the low end of the global range.

Why did the price of Cefuroxime change in Q2 2026 in China?

Clearing the accumulated surplus relieved much of the downward pressure on spot offers, while environmental compliance requirements and intermediate costs nudged the production floor higher. Because capacity remains substantial, the recovery stalled at around USD 232,000/MT.

Cefuroxime Prices in Germany

Germany again commanded the highest prices on the panel at USD 286,000/MT, up about 0.7% from USD 284,000/MT in the first quarter. Energy-intensive production keeps German break-even costs well above those of other markets, and steady European demand for hospital-grade injectable material reinforced that premium through the quarter.

Why did the price of Cefuroxime change in Q2 2026 in Germany?

Demand on the injectable side held firm, and energy and regulatory costs sustained a production floor well above the rest of the panel. German prices closed the quarter near USD 286,000/MT.

Cefuroxime Prices in India

India occupied its customary position in the middle of the range at USD 248,000/MT, a gain of close to 0.8% from USD 246,000/MT. Costlier imported intermediates and a steady stream of orders from domestic formulators together supported the modest advance.

Why did the price of Cefuroxime change in Q2 2026 in India?

Export demand remained active while imported intermediate costs firmed the production base. The combination lifted Indian prices to roughly USD 248,000/MT by the close of the quarter.

For the Quarter Ending March 2026

Cefuroxime Prices Q1 2026:

• United States: USD 276,000/MT
• China: USD 230,000/MT
• Germany: USD 284,000/MT
• India: USD 246,000/MT

Cefuroxime Prices in United States

US prices eased to USD 276,000/MT in the first quarter of 2026, a decline of about 0.4% from the fourth quarter of 2025 and the final stage of the year-long slide. Buyers remained cautious, though the pace of decline had slowed considerably from earlier in the cycle.

Why did the price of Cefuroxime change in Q1 2026 in United States?

A last measure of generic erosion trimmed offers slightly before steadier feedstock costs arrested the fall, and the market held near USD 276,000/MT through the quarter.

Cefuroxime Prices in China

China opened 2026 at USD 230,000/MT, roughly 0.4% below the fourth quarter of 2025. Production resumed after the holiday period into a market still absorbing the surplus carried over from the previous year.

Why did the price of Cefuroxime change in Q1 2026 in China?

Residual inventory kept offers soft, while firmer compliance costs prevented any further meaningful decline, and prices settled near USD 230,000/MT.

Cefuroxime Prices in Germany

Germany recorded USD 284,000/MT in the first quarter, about 0.4% under the fourth quarter of 2025. Elevated energy costs and steady injectable demand kept the market firm at the top of the range even as it eased marginally.

Why did the price of Cefuroxime change in Q1 2026 in Germany?

Energy-linked costs sustained the production base while buyers maintained a measured pace of purchasing, and German prices held near USD 284,000/MT.

Cefuroxime Prices in India

India began the year at USD 246,000/MT, roughly 0.4% below the fourth quarter of 2025, as export demand held and intermediate costs began to level off.

Why did the price of Cefuroxime change in Q1 2026 in India?

Steady offtake met a stabilising feedstock bill, and the market settled at approximately USD 246,000/MT.

Quarterly Cefuroxime Price Trends

Cefuroxime prices declined steadily through 2025 before finding a floor as 2026 began. The global average eased from USD 266,000/MT in the second quarter of 2025 to USD 261,000/MT in the third and USD 256,000/MT in the fourth, then slipped further to USD 253,000/MT in the first quarter of 2026 before recovering to USD 255,000/MT in the second, a net decline of roughly 4.1% across the window. Generic erosion and Chinese oversupply drove the extended decline, while slower discounting and firmer feedstock costs brought it to an end and set the stage for a modest recovery.

What was Cefuroxime Price in 2025?

Cefuroxime prices moved lower through most of 2025 as generic competition and ample Chinese supply pressed on the market. The global average opened the year near USD 272,000/MT and closed around USD 256,000/MT by the fourth quarter, a full-year decline of about 5.9%. Mature end-use demand, persistent generic rivalry, and a well-supplied intermediate chain together set the tone for the year. The floor formed only in the closing months, as the most aggressive price cutting reached its practical limits and firmer feedstock costs began to lend support.

Cefuroxime Prices in United States in 2025

US prices eased from about USD 296,000/MT early in 2025 to USD 277,000/MT by the fourth quarter, a decline of roughly 6.4%. Generic erosion accounted for most of the fall, and with material readily available, importers had little reason to bid the market higher. The decisive variable through the year was the depth of discounting that Chinese and Indian suppliers were prepared to offer.

Cefuroxime Prices in China in 2025

China recorded the steepest decline in absolute terms, from around USD 246,000/MT to USD 231,000/MT, a drop of about 6.1%. Domestic output ran ahead of orders, and exporters trimmed offers to keep product moving. The dynamic was straightforward, with oversupply meeting mature and slow-growing demand.

Cefuroxime Prices in Germany in 2025

Germany eased from roughly USD 303,000/MT to USD 285,000/MT, a decline of close to 5.9%. Cheaper Asian material weighed on European pricing, though high domestic energy costs kept the decline shallow. The interplay of import competition against an elevated home cost base framed the market throughout the year.

Cefuroxime Prices in India in 2025

India moved lower from about USD 263,000/MT to USD 246,000/MT, a fall of 6.5%. Generic price erosion and steady regional supply pressed on the market across the year, with firmer intermediate costs providing only partial support against the trend.

How We Can Help

Expert Market Research: Your Source for Real-Time Cefuroxime Price Intelligence

Expert Market Research maintains continuous coverage of Cefuroxime prices across every major producing and consuming region. Our analysis focuses on the causes behind each movement rather than the headline figure alone, tracing the direction of cephalosporin intermediate costs, the shifting balance of Chinese compliance and capacity, the trajectory of generic demand, and the way trade policy reroutes Asian cargo. Each forecast integrates feedstock economics, trade-flow data, capacity utilisation, and regulatory risk into a single coherent view. For Cefuroxime pricing, analysis tailored to your specific questions, and support with procurement planning, the Expert Market Research team is available to help.